4-BUTYLRESORCINOL

Details

Stereochemistry	ACHIRAL
Molecular Formula	C10H14O2
Molecular Weight	166.217
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

SMILES

CCCCC1=CC=C(O)C=C1O

InChI

InChIKey=CSHZYWUPJWVTMQ-UHFFFAOYSA-N

InChI=1S/C10H14O2/c1-2-3-4-8-5-6-9(11)7-10(8)12/h5-7,11-12H,2-4H2,1H3

HIDE SMILES / InChI

Molecular Formula	C10H14O2
Molecular Weight	166.217
Charge	0
Count	MOL RATIO 1 MOL RATIO (average)

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Approval Year

Targets

Targets

Primary Target	Pharmacology	Condition	Potency
Tyrosinase 41	Inhibitor 8,297		21.0 µM [IC50]

PubMed

Show entries

Title	Date	PubMed
Studies on depigmenting activities of dihydroxyl benzamide derivatives containing adamantane moiety.	2009 Mar 1	19181523
Efficacy and safety of liposome-encapsulated 4-n-butylresorcinol 0.1% cream for the treatment of melasma: a randomized controlled split-face trial.	2010 Apr	20507399
The Efficacy and Safety of 4-n-butylresorcinol 0.1% Cream for the Treatment of Melasma: A Randomized Controlled Split-face Trial.	2010 Feb	20548876
Quasi-drugs developed in Japan for the prevention or treatment of hyperpigmentary disorders.	2010 Jun 18	20640168

Showing 1 to 4 of 4 entries

Previous1Next

Patents

Substance Class	Chemical
Record UNII	2IK4UQ3ZGA
Record Status	`Validated (UNII)`
Record Version

Show entries

Name

Type

Language

4-BUTYLRESORCINOL

Official Name

English

RESORCINOL, 4-BUTYL-

Systematic Name

English

4-n-butylresorcinol [WHO-DD]

Common Name

English

VIVINOL

Brand Name

English

4-BUTYLRESORCINOL [INCI]

Common Name

English

Showing 1 to 5 of 7 entries

Previous1 2Next

Show entries

Code System

Code

Type

Description

DAILYMED

2IK4UQ3ZGA

PRIMARY

EPA CompTox

DTXSID50172403

PRIMARY

CAS

18979-61-8

PRIMARY

RXCUI

1600929

PRIMARY

RxNorm

FDA UNII

2IK4UQ3ZGA

PRIMARY

Showing 1 to 5 of 7 entries

Previous1 2Next